PharmaNutra SpA (IT:PHN) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmaNutra S.p.A. has reported another impressive quarter, showcasing a 17% increase in sales revenues, reaching €83.5 million, and a 27.2% rise in EBITDA compared to the same period last year. The company’s strategic focus on research, development, and innovation has been instrumental in maintaining its growth trajectory. With significant gains in both domestic and international markets, PharmaNutra continues to strengthen its position in the nutritional supplements and medical devices industry.
For further insights into IT:PHN stock, check out TipRanks’ Stock Analysis page.